SCHEMBL21682579

SCHEMBL21682579

COc1ccc(CNc2nc(N3CCCC3COC(=O)CCCC(CO[N+](=O)[O-])O[N+](=O)[O-])ncc2C(=O)NCc2ncccn2)cc1Cl

nearest known ligand 0.66

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 12/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21682583 1.00 PDE5A (0.66) PDE5A
SCHEMBL21705400 1.00 PDE5A (0.66) PDE5A
SCHEMBL31028931 1.00 PDE5A (0.66) PDE5A
SCHEMBL21705399 0.95 PDE5A (0.68) PDE5A
Citric Acid SCHEMBL30951847 0.95 PDE5A (0.60) PDE5A
SCHEMBL23723932 0.93 PDE5A (0.66) PDE5A
SCHEMBL21682625 0.93 PDE5A (0.66) PDE5A
SCHEMBL21682626 0.93 PDE5A (0.66) PDE5A
SCHEMBL21682595 0.93 PDE5A (0.66) PDE5A
SCHEMBL29601312 0.93 PDE5A (0.66) PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3833395-A1 NITRIC OXIDE RELEASING PHOSPHODIESTERASE TYPE 5 INHIBITOR Nicox S.A. (FR) 2021-06-16 EP claimed
WO-2020030489-A1 NITRIC OXIDE RELEASING PHOSPHODIESTERASE TYPE 5 INHIBITOR NICOX S.A. (FR) 2020-02-13 WO claimed
WO-2022090379-A1 NO-PDE5 INHIBITOR FOR USE IN TREATING DRY AGE-RELATED MACULAR DEGENERATION, GEOGRAPHIC ATROPHY AND GLAUCOMA-ASSOCIATED NEURODEGENERATION NICOX S.A. (FR) 2022-05-05 WO disclosed